BRUSSELS, Jan. 31 (Xinhua) -- The European Union's (EU) top health officials held discussions on Sunday with drug giants about rapid development and production of vaccines specially against the new variants of the coronavirus.
The emergence of variants of concern "raises the imminent threat of reduced efficacy of recently approved vaccines," and it is crucial to prepare for the appearance of such variants, the European Commission said in a press release.
